FDA Inspection 1248875 - Lee Duncan Cranmer, MD PhD - September 06, 2024
FDA Inspection 1248875 for Lee Duncan Cranmer, MD PhD on September 06, 2024. Classification: Voluntary Action Indicated (VAI).
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 1248875 for Lee Duncan Cranmer, MD PhD on September 06, 2024. Classification: Voluntary Action Indicated (VAI).
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Lee Duncan Cranmer, MD PhDInspection Date
September 6, 2024
Product Type
Human Drugs
Office
Seattle District OfficeID: f99fefc7-dd3a-4955-b16f-8b7283f1336b
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox